Lijing Yao - Concepedia

Author

Lijing Yao

University of Southern California

Also Known As

Li-Jing Yao, Lijing Yao, Xuming Xu, Yunfei Guo

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of Southern California Cedars-Sinai Medical Center Henry Ford Hospital Van Andel Institute The Ohio State University

About

Lijing Yao is an author at University of Southern California specializing in medicine, gene expression, and functional genomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	224
2	Natural Sciences	2	2	132
3	Cell Biology	2	2	149
4	Molecular Biology	2	2	132
5	Health Sciences	1	1	56

Lijing Yao

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes Lijing Yao, Hui Shen, Peter W. Laird, Genome Biology	2015	210
Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes Adam Blattler, Lijing Yao, Heather Witt, Genome biology	2014	170
ELMER v.2: an R/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles Tiago C. Silva, Simon G. Coetzee, Nicole Gull, Bioinformatics	2018	154
Functional annotation of colon cancer risk SNPs Lijing Yao, Yu Gyoung Tak, Benjamin P. Berman, Nature Communications	2014	124
Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3 Seth Frietze, Rui Wang, Lijing Yao, Genome biology Molecular RegulationMolecular BiologyTranscriptional RegulationSignaling PathwayCell Regulation	2012	113
ZBTB33 binds unmethylated regions of the genome associated with actively expressed genes Adam Blattler, Lijing Yao, Yao Wang, Epigenetics & Chromatin	2013	94
Saccadic eye movements to visual and auditory targets Lijing Yao, C. K. Peck Experimental Brain Research OphthalmologyEye TrackingVision ResearchNeuroscienceVisual Pathway	1997	60
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits Suhn K. Rhie, Yu Guo, Yu Gyoung Tak, Epigenetics & Chromatin	2016	58
Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA). Maximilian Diehn, Ash A. Alizadeh, Hans-Peter Adams, Journal of Clinical Oncology Surgical OncologyAdjuvant ChemotherapyPathologyIii Colorectal CancerTumor Biology	2017	56
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I–IV Non–Small Cell Lung Cancer John Jiang, Hans-Peter Adams, Lijing Yao, Journal of Molecular Diagnostics	2019	52

Page 1